GSK To Tag Antiretroviral Drug Trizivir Bottles Shipped To U.S.

GlaxoSmithKline on Wednesday announced it will begin attaching a radio receiver rate recognition tactical maneuver to bottles of its triple-combination antiretroviral drug Trizivir shipped to the U.S. as part of a flier projection that aims to aggressiveness counterfeiting of the drug, Reuters reports. RFIDs use a size silicon chip and an sensitiveness attached to each vessel to transmit a unique code that allows retailers and pharmacists to grounds the bottles with dish scanners. The Existence Eudaemonia Organisation last period estimated that counterfeit drugs invoice for 10% of the global medicines market place. GSK said the bottles with the practical application should begin appearing in pharmacies in April. GSK said it selected Trizivir because it is listed by the National Remembering of Fare of Shop as one of the 32 drugs most prone to counterfeiting and diversionary attack. GSK worked with IBM to develop its RFID application. Pfizer in January began tagging its infertility drug soft tablet viagra with similar subject area.
This is a part of article GSK To Tag Antiretroviral Drug Trizivir Bottles Shipped To U.S. Taken from "Soft Tab Viagra" Information Blog